The Latest
FDA approves new formulation of Hyrimoz adalimumab biosimilar
The agency approved a higher-concentration formulation of Hyrimoz for its previous indications, including rheumatoid arthritis and psoriasis.
Latest News
March 28, 2023
DMARDs taper-to-discontinuation trial deemed inconclusive
March 28, 2023
MDedge Rheumatology
March 27, 2023
Luxe vacations, private jets: Medical device maker, surgeon to pay $46 million penalty in kickback scheme
March 27, 2023
MDedge Rheumatology
Rheumatoid Arthritis
March 28, 2023
DMARDs taper-to-discontinuation trial deemed inconclusive
March 28, 2023
MDedge Rheumatology
March 27, 2023
FDA approves new formulation of Hyrimoz adalimumab biosimilar
March 27, 2023
MDedge Rheumatology
March 24, 2023
Tofacitinib may have possible protective effect against ILD in RA
March 24, 2023
MDedge Rheumatology
March 24, 2023
New JAK inhibitor study data confirm benefit in alopecia areata
March 24, 2023
AAD: American Academy of Dermatology
MDedge Rheumatology
March 19, 2023
JAK inhibitor safety warnings drawn from rheumatologic data may be misleading in dermatology
March 19, 2023
AAD: American Academy of Dermatology
MDedge Rheumatology
March 6, 2023
Call it preclinical or subclinical, ILD in RA needs to be tracked
March 6, 2023
MDedge Rheumatology
Conference Coverage
March 27, 2023
New data forecast more oral PDE4 inhibitors for psoriasis
March 27, 2023
AAD: American Academy of Dermatology
MDedge Rheumatology
March 24, 2023
New JAK inhibitor study data confirm benefit in alopecia areata
March 24, 2023
AAD: American Academy of Dermatology
MDedge Rheumatology
March 24, 2023
Link between knee pain, sleep disturbance related to daily activities
March 24, 2023
OARSI: OsteoArthritis Research Society International
MDedge Rheumatology
Business of Medicine
March 27, 2023
Luxe vacations, private jets: Medical device maker, surgeon to pay $46 million penalty in kickback scheme
March 27, 2023
MDedge Rheumatology
March 23, 2023
Celebrity death finally solved – with locks of hair
March 23, 2023
MDedge Rheumatology
March 23, 2023
Nurse makes millions selling her licensing exam study sheets
March 23, 2023
MDedge Rheumatology
Psoriatic Arthritis
March 27, 2023
FDA approves new formulation of Hyrimoz adalimumab biosimilar
March 27, 2023
MDedge Rheumatology
March 27, 2023
New data forecast more oral PDE4 inhibitors for psoriasis
March 27, 2023
AAD: American Academy of Dermatology
MDedge Rheumatology
March 23, 2023
Psoriatic arthritis treatment for women falls short, study suggests
March 23, 2023
MDedge Rheumatology
March 9, 2023
Biologics show signs of delaying arthritis in psoriasis patients
March 9, 2023
MDedge Rheumatology
Coronavirus Updates
March 10, 2023
FREEDOM COVID: Full-dose anticoagulation cut mortality but missed primary endpoint
March 10, 2023
ACC: American College of Cardiology
MDedge Rheumatology
February 13, 2023
Prehospital COVID therapy effective in rheumatic disease patients
February 13, 2023
MDedge Rheumatology
Osteoporosis
March 20, 2023
Holy smoke: Air pollution link to bone damage confirmed
March 20, 2023
MDedge Rheumatology
March 1, 2023
U.S. vs. French guidelines for osteoporosis treatment
March 1, 2023
MDedge Rheumatology
Clinical Edge Journal Scan
March 1, 2023
Commentary: ILD and other issues in RA treatment, March 2023
March 1, 2023
MDedge Rheumatology
March 1, 2023
Commentary: Concerning PsA treatments and comorbidities, March 2023
March 1, 2023
MDedge Rheumatology
February 1, 2023
Commentary: Glucocorticoid use and progression in RA, February 2023
February 1, 2023
MDedge Rheumatology
January 30, 2023
Commentary: Early Diagnosis of PsA, February 2023
January 30, 2023
MDedge Rheumatology